Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

active_not_recruiting125%
completed250%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
completednot_applicable

The Peer Genetic Study

NCT05011799
active_not_recruitingnot_applicable

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

NCT04496739
completednot_applicable

Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients

NCT03929926
terminatednot_applicable

Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

NCT03943082

Clinical Trials (4)

Showing 4 of 4 trials
NCT05011799Not Applicable

The Peer Genetic Study

Completed
NCT04496739Not Applicable

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Active Not Recruiting
NCT03929926Not Applicable

Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients

Completed
NCT03943082Not Applicable

Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

Terminated

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4